Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (181-190 of 337) with videos related to

Pageof 34
Sort By:
Frontiers in Immunology|June 21, 2024
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responsesTim R Mosmann, Jonathan A Rebhahn, Stephen C De Rosa, et al.
Virology|January 13, 2006
HIV-1 subtype C in vitro growth and coreceptor utilizationThumbi Ndung'u, Enoch Sepako, Mary Fran McLane, et al.
The Journal of Infectious Diseases|July 24, 2013
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infectionHolly Janes, David P Friedrich, Amy Krambrink, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Biostatistics (Oxford, England)|June 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine developmentPeter B Gilbert, James Peng, Larry Han, et al.
Plos One|June 17, 2020
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin AmericaLindsay N Carpp, Youyi Fong, Matthew Bonaparte, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2023
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trialNima S Hejazi, Xiaoying Shen, Lindsay N Carpp, et al.
The Journal of Infectious Diseases|February 3, 2005
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trialPeter B Gilbert, Michael L Peterson, Dean Follmann, et al.
Plos Computational Biology|November 14, 2024
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studiesLin Lin, Rachel L Spreng, Kelly E Seaton, et al.
The American Journal of Tropical Medicine and Hygiene|May 23, 2019
Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody ResponsePeter B Gilbert, Ying Huang, Michal Juraska, et al.
Pageof 34

Showing results (181-190 of 337) with videos related to

Sort By:
Pageof 34
Frontiers in Immunology|June 21, 2024
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responsesTim R Mosmann, Jonathan A Rebhahn, Stephen C De Rosa, et al.
Virology|January 13, 2006
HIV-1 subtype C in vitro growth and coreceptor utilizationThumbi Ndung'u, Enoch Sepako, Mary Fran McLane, et al.
The Journal of Infectious Diseases|July 24, 2013
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infectionHolly Janes, David P Friedrich, Amy Krambrink, et al.
AIDS (London, England)|July 4, 2006
Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in BotswanaRoger L Shapiro, Ibou Thior, Peter B Gilbert, et al.
Biostatistics (Oxford, England)|June 22, 2025
A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine developmentPeter B Gilbert, James Peng, Larry Han, et al.
Plos One|June 17, 2020
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin AmericaLindsay N Carpp, Youyi Fong, Matthew Bonaparte, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2023
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trialNima S Hejazi, Xiaoying Shen, Lindsay N Carpp, et al.
The Journal of Infectious Diseases|February 3, 2005
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trialPeter B Gilbert, Michael L Peterson, Dean Follmann, et al.
Plos Computational Biology|November 14, 2024
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studiesLin Lin, Rachel L Spreng, Kelly E Seaton, et al.
The American Journal of Tropical Medicine and Hygiene|May 23, 2019
Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody ResponsePeter B Gilbert, Ying Huang, Michal Juraska, et al.
Pageof 34